静心止动方治疗抽动障碍疗效观察及免疫相关性研究
[Abstract]:Objective:1. The incidence of TD was investigated by comparing the levels of IL-6 and TNF-1 in the serum of the patients with TD before and after treatment, the level of different conditions, and the level difference with the control group. The relationship between the severity of the disease and the levels of IL-6 and TNF-1 and the influence of age and sex were also explored. By observing the changes of IL-6 and TNF-1 content in the serum of the children with TD in 3 months after the treatment, the effect of the treatment TD of the static-heart stop was assessed in combination with the improvement of the clinical symptom. This paper reveals the target of the treatment of TD, and it is clear from the angle of modern medicine that the mechanism of the treatment of TD is clear and the dialectical thinking of the "the treatment of heart disease" is verified. The correlation of this disease was discussed from the aspects of cellular immunity in combination with the experimental results and the related literature of the pathogenesis of TD. Methods: The subject of this study was the TD and the normal children of the pediatric outpatient department of the Guangan Men's Hospital of the Chinese Academy of Chinese Medicine. The diagnosis standard of the patients with TD was determined by the DSM-V. The screening and elimination of the cases were carried out in strict accordance with the requirements of the enrollment,74 cases of the case group and 20 cases of the control group were retained. All patients were treated with the static-heart stop for 3 months, and the scores of the Yale Comprehensive Stroke Severity Scale (YGTSS) were used to assess the severity of the symptoms of the pre-and post-treatment, and the efficacy was evaluated with reference to the score reduction rate before and after the treatment. The whole course of treatment was to ensure the safety of the liver and kidney function and the urine routine of the child. All the children who were enrolled in the pre-treatment and in the TD group were collected for 2 ml of venous blood, and the upper serum was collected at-80.degree. C. for 10 minutes at 4.degree. C. for 10 minutes and then stored at-80.degree. C. for detection. The levels of TNF-1 and IL-6 were detected by the chemiluminescence method using the dpc immulite 1000 chemiluminescent immunoassay. The equipment manufacturer is the German Siemens, the kit is the original kit of the company, and the batch number is 0262. All the experiments of the subject are completed in the Laboratory of the Guangan Men's Hospital of the Chinese Academy of Chinese Medicine, and are strictly operated according to the instructions of the kit. The statistical processing was carried out using the SPSS19.0 statistical software, and the measurement data was expressed as the standard deviation of the mean number. The analysis methods such as the paired sample t test, the independent sample t test, the non-parametric Mann-Whitney U test, the Spearman double-variable correlation test and the non-parametric Kruskal-Wallis H (K) were used. Results: 1.74 patients with TD were treated by the static-heart stop for 3 months, and the total effective rate was 79.7%. The serum TNF-1 level in the patients with TD was higher than that in the control group (P0.01), and the level of IL-6 was not significant. The level of TNF-1 in the patients with TD was higher than that in the control group, and the level of IL-6 was lower than that in the control group (P0.05). There was no significant difference in the level of IL-6. The lower the score of YGTSS (r =-0.249, P0.05), the lower the level of serum TNF-6 (r =-0.303, P0.01). There was a significant difference in serum TNF-1 level among children with mild, moderate and severe TD (P0.01). The higher the level of serum TNF-1, the higher the level of TNF-1 in the serum, and there was no significant difference with the control group, and there was no significant difference in the level of IL-6. The higher the serum TNF-1 level in the children with higher YGTSS scores before the treatment, the higher the serum TNF-1 level (r = 0.956, 0.929, P0.01); the correlation between the YGTSS score and the IL-6 level was not statistically significant. Conclusion:1. In this study, the total effective rate was 79.7% after the treatment with the static-heart stop, and the liver and kidney function of all the children after treatment had no abnormality. The results confirm the effectiveness and safety of Professor Han Fei's "the treatment of heart disease" on the treatment theory and the "static-core stop" of the self-proposed formula. The serum TNF-1 level in the children with TD was higher than that of normal children and decreased after treatment. There was no significant difference between the level of IL-6 and normal children. It is suggested that the pathogenesis of TD is related to the disorder of the immune function of the body. The results suggested that the boy was more likely to have the disease than the girl, and most of the female patients had a mild condition, and the male child was relatively more severe, and it was presumed that the difference in the immune and nervous system development between the male and the female was related to that of the male and female. The higher the severity of the disease, the higher the serum TNF-1 level in the patients with the higher the YGTSS score, and the difference of IL-6 was not statistically significant. Therefore, the TNF-1 level can be considered as a reference index for judging the severity of the extraction. The lower the score of YGTSS, the lower the level of serum TNF-6, the lower the level of serum TNF-6, and the difference between the age of the children and the level of IL-6 in the serum. It may be related to the development of the immune and nervous system of the children with larger age.
【学位授予单位】:北京中医药大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R277.7
【参考文献】
相关期刊论文 前10条
1 徐欣欣;;阿立哌唑用于抽动障碍中对疗效和患儿依从性的影响[J];世界最新医学信息文摘;2015年30期
2 孙莹;王惠萍;段丽芬;;阿立哌唑治疗抽动障碍的临床疗效和安全性[J];中国医药科学;2014年21期
3 刘艳艳;陈燕惠;;亚氨基二丙腈构建的抽动障碍大鼠脑组织IL-6及TNF-α变化及意义[J];中国神经免疫学和神经病学杂志;2014年05期
4 薛德馨;彭丽娜;;从风论治小儿多发性抽动症[J];四川中医;2014年08期
5 谭润果;赵坤;;赵坤教授治疗抽动-秽语综合征的经验[J];光明中医;2014年05期
6 李博涵;;单独二胎政策的出台对我国人口规模及结构的影响研究[J];知识经济;2014年02期
7 袁仙丽;李明才;李燕;高雪明;高巧艳;;白细胞介素-38及其相关细胞因子在炎症中的作用[J];中国细胞生物学学报;2013年08期
8 李建保;徐荣谦;;徐荣谦治疗多发性抽动症临床经验拾萃[J];辽宁中医杂志;2013年02期
9 胡细佑;吴远华;朱广旗;;朱广旗教授治疗小儿抽动症经验[J];内蒙古中医药;2012年18期
10 张骠;隆红艳;章金春;;静安口服液对多发性抽动症儿童中枢神经递质的影响[J];中国中西医结合杂志;2012年07期
相关硕士学位论文 前6条
1 汪琼;静心止动方治疗TD及其对T淋巴细胞亚群影响的研究[D];北京中医药大学;2016年
2 任思洋;静心止动方治疗中重度TD及对神经递质影响的研究[D];北京中医药大学;2014年
3 汤海霞;宁动颗粒对抽动—秽语综合征患儿血清白细胞介素-12、肿瘤坏死因子-a的影响[D];山东大学;2013年
4 田雪;静心止动方治疗抽动障碍的免疫及神经生化机制研究[D];北京中医药大学;2013年
5 季金萍;T细胞免疫及相关心理社会因素与儿童抽动障碍关系的研究[D];大连医科大学;2011年
6 毛莹莹;抽动秽语综合征患儿血清中白细胞介素-12和肿瘤坏死因子-α水平变化研究[D];吉林大学;2008年
,本文编号:2471333
本文链接:https://www.wllwen.com/zhongyixuelunwen/2471333.html